Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
CardieX ( (AU:CQT) ) just unveiled an update.
Conneqt Health Limited reported its Appendix 4C quarterly cash flow for the period ended 31 December 2025, showing net operating cash outflows of A$1.9 million for the quarter and A$4.5 million for the half year, as customer receipts and government grants did not fully offset spending on research and development, marketing, staff, and corporate costs. The company recorded minimal investing cash flows, while strengthening its balance sheet through A$2.0 million in new equity and A$1.0 million in convertible debt for the quarter, resulting in a net increase in cash and cash equivalents and indicating continued reliance on capital markets to fund operations and growth initiatives.
More about CardieX
Conneqt Health Limited, formerly CardieX Limited, operates in the health technology sector, focusing on medical and health monitoring solutions, with a business model built around commercialising its products and services globally.
Average Trading Volume: 585,224
Technical Sentiment Signal: Sell
Current Market Cap: A$27.56M
For an in-depth examination of CQT stock, go to TipRanks’ Overview page.

